COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE

Autor: E. V. Derkach, V. V. Omel'yanovskiy, Tereshchenko Sn, P. M. Khaylov
Jazyk: angličtina
Rok vydání: 2016
Předmět:
medicine.medical_specialty
lcsh:Diseases of the circulatory (Cardiovascular) system
thrombolysis
myocardial infarction with st segment elevation
Cost effectiveness
medicine.medical_treatment
Tenecteplase
RM1-950
Bolus (medicine)
Internal medicine
чрескожное коронарное вмешательство
medicine
ST segment
Diseases of the circulatory (Cardiovascular) system
Pharmacology (medical)
Myocardial infarction
cardiovascular diseases
тенектеплаза
tenecteplase
business.industry
lcsh:RM1-950
percutaneous coronary intervention
Percutaneous coronary intervention
Thrombolysis
medicine.disease
реперфузия
reperfusion
lcsh:Therapeutics. Pharmacology
surgical procedures
operative

lcsh:RC666-701
RC666-701
Conventional PCI
тромболизис
Cardiology
инфаркт миокарда с подъемом ST
Therapeutics. Pharmacology
Cardiology and Cardiovascular Medicine
business
medicine.drug
Zdroj: Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 7, Iss 2, Pp 145-150 (2016)
ISSN: 2225-3653
1819-6446
Popis: Aim. To evaluate clinical and cost effectiveness of different reperfusion strategies in myocardial infarction with ST segment elevation (STEMI), including pre-hospital thrombolysis with tenecteplase. Material and methods. Methods of cost-effectiveness analysis and economic modeling were used to calculate the costs of reperfusion in STEMI, expected number of life gains, the cost of life gains depending on reperfusion strategy (no reperfusion, percutaneous coronary intervention (PCI), prehospital thrombolysis, hospital thrombolysis). Results. In accordance to analysis results and from economic point of view, the most effective strategy is primary PCI in patients within "therapeutic window" and pre-hospital thrombolysis in the remaining patients with STEMI. More complex strategy of patients flow control with patient division into groups of primary PCI, pre-hospital thrombolysis and hospital thrombolysis lead to decrease in reperfusion costs efficacy. Conclusion. The reperfusion model with primary PCI in the first 120 minutes after STEMI symptoms onset, and pre-hospital thrombolysis with bolus thrombolytic administration, when PCI is not possible in this period, is the most effective economically and in respect on mortality reduction in patients with STEMI.
Databáze: OpenAIRE